← Back to Search

Nutritional Supplements for Ovarian Cancer

Phase 2
Waitlist Available
Led By Beverly C. Handy, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Epithelial ovarian cancer of (any tumor type). Stages 2 and up.
In first clinical remission. (CA125 < 35)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 months
Awards & highlights

Study Summary

This trial will compare the effects of adding Juice Plus+ and Juice Plus+ Complete to the diet of ovarian cancer patients receiving only dietary counseling.

Who is the study for?
This trial is for women over 21 with epithelial ovarian cancer, stages 2 or higher, who are in their first clinical remission. Participants must be able to eat normally (not on IV nutrition), have a BMI over 19.5, and a life expectancy of at least six months. Pregnant or breastfeeding women, those with bowel obstruction or on restricted diets due to other illnesses cannot join.Check my eligibility
What is being tested?
The study is testing if adding Juice Plus+ supplements and Juice Plus+ Complete shakes to the diet improves outcomes for ovarian cancer patients compared to just receiving nutritional counseling without these supplements.See study design
What are the potential side effects?
Potential side effects may include digestive issues due to high fiber content in the supplements which might not suit everyone's stomachs especially those with certain medical conditions that require a restricted diet.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My ovarian cancer is stage 2 or higher.
Select...
My CA125 levels are below 35, indicating I am in my first clinical remission.
Select...
I am over 21 years old.
Select...
I can walk and eat on my own without needing IV nutrition.
Select...
I am older than 21 years.
Select...
I can walk and eat on my own without needing IV nutrition.
Select...
My ovarian cancer is stage 2 or higher.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in levels of serum carotenoid resulting from nutritional supplements or dietary counseling
Body Weight Changes

Trial Design

2Treatment groups
Experimental Treatment
Group I: Nutritional CounselingExperimental Treatment1 Intervention
For 6 months control group receives dietary counseling.
Group II: Daily SupplementsExperimental Treatment1 Intervention
2 capsules (Juice Plus+) twice a day (morning and evening) plus Juice Plus+ Complete drink each evening for 6 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nutritional Counseling
2016
Completed Phase 2
~560

Find a Location

Who is running the clinical trial?

Natural Alternatives InternationalUNKNOWN
M.D. Anderson Cancer CenterLead Sponsor
2,974 Previous Clinical Trials
1,789,399 Total Patients Enrolled
46 Trials studying Ovarian Cancer
16,670 Patients Enrolled for Ovarian Cancer
Beverly C. Handy, MDPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Daily Supplements Clinical Trial Eligibility Overview. Trial Name: NCT01439659 — Phase 2
Ovarian Cancer Research Study Groups: Nutritional Counseling, Daily Supplements
Ovarian Cancer Clinical Trial 2023: Daily Supplements Highlights & Side Effects. Trial Name: NCT01439659 — Phase 2
Daily Supplements 2023 Treatment Timeline for Medical Study. Trial Name: NCT01439659 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research offer opportunities for patient participation?

"Clinicaltrials.gov reveals that this trial is not actively seeking participants, as it was initially posted on February 18th 2003 and last edited June 29th 2022. Nevertheless, 676 other trials are searching for patients currently."

Answered by AI

Has the FDA authorized Daily Supplements for public usage?

"Given the data from Phase 2 trials, our team at Power judged Daily Supplements to have a safety rating of 2. Although there is evidence showing its security, none exists yet that proves their efficacy."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
University of Texas MD Anderson Cancer Center
What portion of applicants met pre-screening criteria?
Met criteria
~3 spots leftby Apr 2025